Let Archived Paraffin Blocks Be Utilized for Research with Waiver of Informed Consent
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Advances in biomedical and genetic research have contributed to more effective public health improvement via bench-to-bed research and the emergence of personalized medicine. This has certainly showcased the importance of archived human tissues, especially paraffin-embedded blocks in pathology. Currently in Korea, undue legislative regulations of the Bioethics and Safety Act suspend and at times discourage studies from taking place. In this paper, the authors underline the value of paraffin blocks in the era of personalized and translational medicine. We discuss detailed clauses regarding the applicability of paraffin blocks from a legal perspective and compare Korea’s regulations with those of other countries. The necessity for allowing waived consent and Institutional Review Board (IRB) approval will be argued throughout. The authors suggest that researchers declare the following to obtain IRB approval and waiver of informed consents: research could not be practically carried out without a waiver of consent; the proposed research presents no more than minimal risk of harm to subjects, and the waiver of consent will not adversely affect the rights and welfare of subjects; and research will not utilize a tissue block if only 1 is available for each subject, to allow future clinical use such as re-evaluation or further studies.
Abstract
Advances in biomedical and genetic research have contributed to more effective public health improvement via bench-to-bed research and the emergence of personalized medicine. This has certainly showcased the importance of archived human tissues, especially paraffin-embedded blocks in pathology. Currently in Korea, undue legislative regulations of the Bioethics and Safety Act suspend and at times discourage studies from taking place. In this paper, the authors underline the value of paraffin blocks in the era of personalized and translational medicine. We discuss detailed clauses regarding the applicability of paraffin blocks from a legal perspective and compare Korea’s regulations with those of other countries. The necessity for allowing waived consent and Institutional Review Board (IRB) approval will be argued throughout. The authors suggest that researchers declare the following to obtain IRB approval and waiver of informed consents: research could not be practically carried out without a waiver of consent; the proposed research presents no more than minimal risk of harm to subjects, and the waiver of consent will not adversely affect the rights and welfare of subjects; and research will not utilize a tissue block if only 1 is available for each subject, to allow future clinical use such as re-evaluation or further studies.
참고문헌 (13)
- 류영준, "한국의 연구중심병원의 연구용 인체조직 관리체계 향상을 위한 제언", 대한의사협회지, 55(3), pp.292~303 (2012), 대한의사협회
- McDonald SA, "Principles of research tissue banking and specimen evaluation from the pathologist's perspective", Biopreserv Biobank, 8, pp.197~201 (2010)[DOI]
- 이한주, "생명윤리법 상 인체유래물 연구를 위한 심의·동의제도의 법적 검토", 강원법학, 45, pp.479~516 (2015), 비교법학연구소[DOI]
- Information Portal of Institutional Review Boards designated by the Ministry of Health and Welfare, "100 Questions and 100 answers. 2013 to 2014 collection of open writings 30", Ministry of Health and Welfare, ~ (2015)
- "Exception from general requirements for informed consent (21 CFR 50.23(e))" (2017)[URL]
- "Attachment D: FAQ's terms and recommendations on informed consent and research use of biospecimens" (2011)[URL]
- "Code of Federal Regulations (CFR) title 45 part 46" (2017)[URL]
- Dry S, "Who owns diagnostic tissue blocks?", Lab Med, 40, pp.69~73 (2009)[DOI]
- [URL]
- [URL]
- [URL]
- The Royal College of Pathologists of Australasia, "The ethical and legal issues in relation to the use of human tissue and test results in Australia" (2014)
- [URL]
